XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
  Diabetes
   NIDDM
   Insulin Resistance
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

Diabetes Channel
subscribe to Diabetes newsletter

Latest Research : Endocrinology : Diabetes

   DISCUSS   |   EMAIL   |   PRINT
High blood glucose impairs coronary vasodilation in diabetics
Oct 8, 2005, 23:57, Reviewed by: Dr.

Normally, when the heart pumps harder, the blood vessels that feed it open wider to bring the heart more fuel. Poorly controlled blood glucose levels in type I diabetes can have a negative effect on blood flow to the heart.

 
In the heart muscle of type 1 diabetics, high blood glucose is a significant contributor to poorly opening vessels, or poor vasodilation, according a study by researchers at Washington University School of Medicine in St. Louis. Even administration of high levels of insulin, which usually enhances vasodilation, can't counteract the negative effect of high glucose on the heart.

"Since it is typical for type 1 diabetics to periodically experience insulin deficits or increased blood glucose, we systematically isolated the effect of insulin and glucose to see which had a greater effect on dilation of blood vessels in these patients."

The researchers measured the capacity of heart blood vessels to dilate in 20 patients with type 1 diabetes using positron emission tomography (PET) imaging. Other than their diabetes, the patients had no physical conditions, such as coronary disease, hypertension or high cholesterol, which would contribute to impaired vasodilation. The team used the drug adenosine to encourage dilation of the blood vessels of the heart, and at the same time they maintained constant insulin and glucose levels in the patients using an intravenous system.

The researchers found that in response to adenosine, patients maintained at high insulin and normal glucose levels increased the rate of blood flow in the heart about four fold. But patients maintained at high insulin and high glucose increased their heart blood flow rate only about two fold.

"We know that insulin has beneficial effects on vasodilation," Gropler says. The study demonstrates the detrimental effect of high glucose levels on heart function and highlights the importance for diabetic patients of keeping their blood glucose within the normal range.

"It can be very challenging for diabetic patients to maintain normal blood sugar," says co-author Janet B. McGill, M.D., associate professor of medicine. "But this study provides yet another reason to push for tight control of glucose levels. If instituted early enough, tight glycemic control may potentially reduce heart problems in diabetic patients."

The study's authors note that high blood glucose reduces production of nitrous oxide, a substance that contributes to vasodilation, and increases production of hormones that constrict blood vessels. It also increases oxidative stress in tissues of the body by altering cellular energy metabolism.

"The heart has become an organ of primary concern for endocrinologists and people with diabetes," McGill says. Robert Gropler
Robert Gropler

"We are focusing on blood fat levels in this next study," Gropler says. "We want to see if drugs that reduce blood fat levels and thus decrease fat delivery to the heart will have beneficial effects on the metabolism of heart muscle as well as blood flow and heart function."
 

- Srinivasan M, Herrero P, McGill JB, Bennik J, Heere B, Lesniak D, Davila-Roman VG, Gropler RJ. The effects of plasma insulin and glucose on myocardial blood flow in patients with type I diabetes mellitus. Journal of the American College of Cardiology 2005 July 5;46(1):42-48.
 

www.wustl.edu

 
Subscribe to Diabetes Newsletter
E-mail Address:

 

Funding from the National Institutes of Health and the Barnes-Jewish Hospital Foundation supported this research.

Washington University School of Medicine's full-time and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient care institutions in the nation, currently ranked third in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.


Related Diabetes News

Diabetes is an independent predictor of acute organ failure and subsequent death
Insulin resistance in early teens may predict diabetes
Low-fat vegan diet rivals oral diabetes medications
Conjugated linoleic acids in dairy products targets diabetes
TrialNet - Can Type 1 diabetes be prevented?
Infections Link With diabetes
Netrins hold potential for treating diabetes
Coffee might reduce risk of type 2 diabetes
Race may be risk factor for insulin resistance
Impaired blood vessel responses seen in children of diabetics


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us